T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts

NCT00368355 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Non Hodgkins Lymphoma
Myelodysplastic Syndrome
Acute Myeloid Leukemia
Chronic Myelogenous Leukemia
Hemophagocytic Lymphohistiocytosis (HLH)
Familial Hemophagocytic Lymphohistiocytosis (FLH)
Viral-associated Hemophagocytic Syndrome (VAHS)
X-linked Lymphoproliferative Disease (XLP)

Interventions

DRUG: Ara-C
DRUG: Cyclophosphamide
BIOLOGICAL: Campath-1H
RADIATION: Total Body Irradiation
PROCEDURE: Stem Cell Infusion

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]